Here are the models. They're all based on the acoustic shock paper and the cochlea Type II sensitization research. They might be a bit crude and patchy in places but the aim of them is to combine the 2 theories above in various ways.
They take a bit of understanding so may need reading several times and it would help to also read the above papers and research (linked earlier in this thread) for some preliminary background.
They naturally seem to fall into self propelling cycles that could go on endlessly. The apparent 'fuel' for the cycles seems to be inflammation that once subsides is what finally breaks the cycle. The potential triggers for the cycles are more complex and could start in various places.
If there's any obvious errors in these please point them out and I'll fix them if any of it is easily debunk-able then that's good as well as it reduces the number of theories.
In case you've not seen these types of diagrams before, just start at the noise entering the ear and then just follow the arrows, they normally end up cycling in some way.
1.01 - Initial Acoustic Shock Triggered by Cochlea OHC Damage / Type II Sensitization
This model proposes that the acoustic shock is triggered by the sensitization of Type II afferents due to damaged OHC in the cochlea that then send pain signals through the central nervous system back to the middle ear telling it to protect the cochlea. It results in the hypercontraction of the tensor tympani leading to the acoustic shock symptoms cluster. Depending on the severity and duration of the acoustic shock symptoms cluster plus the noxious noise exposure time, there could be a range of damage from no significant lasting damage (acute), to mid ear inflammation leading to possible further cochlea damage (Type II sensitization), through to mid ear inflammation plus trigeminal nerve sensitization. Cochlea inflammation may also stimulate the TGN cochlea nerve endings.
This could explain why people suffer varying degrees of symptoms post acoustic shock, ranging from a seemingly quick and full recovery, to frequency specific noise sensitivity and acute pain, through to delayed lingering facial pain, modulated tinnitus, and setbacks etc. It also assumes that even though there may possibly be no significant mid ear damage as a result of the first acoustic shock, the threat of repeat and more severe setbacks and acoustic shocks remains due to the permanent OHC damage and Type II sensitization in the cochlea, and could also explain the accumulative nature of hearing damage, the worsening of symptoms, and the lowering of threshold for setbacks over time.
If, in this scenario the mid ear and cochlea inflammation were allowed to rest and recover in silence and return to a tolerable (albeit fragile) baseline as indeed they can do, it is perceivable that the threat of setbacks could be neutralized if the damaged OHC can be regenerated with something like FX-322. Other drugs like SPI-1005 and maybe synapse drugs may have further positive effect.
2.01 - Initial Acoustic Shock Triggered by Tensor Tympani Muscle Hypercontraction
This model proposes that the acoustic shock is triggered by the cochlea sending sound signals to the cochlear nucleus / CNS via Type I afferents and not Type II, where it then gets perceived to be a noxious noise resulting in a signal being sent to the middle ear telling it to protect the cochlea. It results in the hypercontraction of the tensor tympani leading to the acoustic shock symptoms cluster. Depending on the severity and duration of the acoustic shock symptoms cluster plus the noxious noise exposure time, there could be a range of damage from no significant lasting damage (acute), to mid ear inflammation leading to possible cochlea damage (Type II sensitization), through to mid ear inflammation plus trigeminal nerve sensitization. In addition to the above damage being done by the acoustic shock symptoms cluster to the mid ear and TGN, the noxious noise (if duration of exposure was long enough) may also now have caused hearing loss, and led to enough OHC damage to cause Type II sensitization directly in the cochlea. This Type II sensitization could now further exacerbate the acoustic shock symptoms cluster, as well as become the potential trigger of frequency specific sensitivity / pain, and further setbacks and acoustic shocks once the initial acoustic shock had been seemingly recovered from. Cochlea inflammation may also stimulate the TGN cochlea nerve endings.
A third causal model could suggest a combination of the 2 above models. Noxious noise causes sensitization of Type II afferents and then proceeds to simultaneously send both pain signals on Type II afferents whilst also sending sound signals on the Type I afferents that are perceived to be noxious and therefore having a synchronized 2 tiered impact on how the acoustic shock affects the mid ear.
These models could suggest that a centralized, heightened neural response to noise may remain even after initial recovery, that now runs independently upon exposure to even non noxious sound. If cochlea damage was repaired by some combination of FX-322, SPI-1005, and maybe also synapse drugs, and the mid ear environment was allowed to also recover, the concern would be that the mid ear response to noise is now heightened and could possibly lead to needless hyper contraction of the TTM and further acoustic shocks at non noxious noise levels resulting once again in mid ear inflammation and TGN stimulation (delayed facial pain). However, to put a positive spin on this scenario, if the cochlea was now repaired and not subject to any further non-noxious frequency specific noise damage/stimulation, this model may indicate that only the mid ear is now at risk of further damage by a newly perceived noxious noise level across
all frequencies. It is presumably no longer at risk of damage via frequency specific stimulation of Type II afferents in the cochlea where the damaged OHCs have now been regenerated as presumably, OHC support cells will no longer release ATP. But, if new mid ear inflammation can possibly cause ATP to diffuse through the round window, can this ATP stimulate the previously sensitized Type II afferents or cause repeat OHC damage? The middle ear is also presumably now no longer at risk of setbacks if they indeed do originate in a damage cochlea.
The fact that tolerance to noise does improve as recovery goes on suggests that this is not permanent however.
Of course, a brand new instance of genuinely noxious noise induced cochlea damage remains a possibility.
3.01 - Long Recovery & Repeat Setbacks Now Become A Result Of Noise Exposure To Cochlea & TTM
This model proposes a 2 point effect on possibly why it takes so long to recover after an acoustic shock as well as what could be responsible for setback. In effect there are 2 ongoing conditions running in parallel.
It assumes that once the middle ear has been damaged by an acoustic shock symptoms cluster that it remains vulnerable to
any noise. The fact that it is physically moving at all and unable to immobilize and rest and repair leads to a constant state of inflammation that continues to affect the facial muscles, modulate tinnitus, and cause other hearing distortions hence the need to avoid all sound in order to let this damage heal. If there are other reasons why the middle ear may still be active even during silence such as even blinking it could add more reason why it takes so long to recover from the facial pain.
It also assumes that running in parallel are the sensitized cochlea Type II afferents that are still acting as nociceptors upon hearing specific frequencies. This part of the model proposes ATP sensitized Type II's continue to send pain signals to the middle ear to protect the cochlear, and therefore putting an already damaged and inflamed middle ear under even more strain, also raising the likelihood of setbacks and even further acoustic shocks.
This could suggest why tolerance to sound generally increases over time, and why symptoms such as facial pain, modulated tinnitus, and hearing distortions do settle after long recovery periods particularly in silence. Importantly these particular symptoms do not seem to be permanent. It could also explain why certain frequencies cause instant acute pain that leads to repeat setbacks. Finally it could explain why no matter how well recovery seems to be going the possibility of setbacks remain a threat due to the permanent OHC damage and Type II sensitization in the cochlea.
If in this scenario the mid ear and cochlea inflammation were allowed to rest and recover in silence and return to a tolerable (albeit fragile) baseline, it is perceivable that if the cochlea damage can be repaired by a regenerative treatment so that the nociceptors no longer responded to frequency specific noxious noise it would break the setback cycle.
4.01 - Long Recovery & Repeat Setbacks Now Become A Result Of Noise Exposure To Cochlea & TTM & Heightened Neural Responsiveness
This model proposes a 3 point attack on the mid ear due to an already damaged and inflamed cochlea, TTN and mid ear environment, sensitization of TGN, sensitization of cochlea Type II afferents, plus an independent, centralized, and heightened neural response to even non noxious noise.
It firstly assumes that once the middle ear has been damaged by an acoustic shock symptoms cluster that it remains vulnerable to
any noise. The fact that it is physically moving at all and unable to immobilize and rest and repair leads to a constant state of inflammation that continues to affect the facial muscles, modulate tinnitus, and cause other hearing distortions hence the need to avoid all sound in order to let this damage heal. If there are other reasons why the middle ear may still be active even during silence such as blinking it could add more reason why it takes so long to recover from facial pain.
It also assumes that running in parallel are the sensitized cochlea Type II afferents that are still acting as nociceptors upon hearing specific frequencies. This part of the model proposes ATP sensitized Type II's continue to send pain signals to the middle ear to protect the cochlear, and therefore putting an already damaged and inflamed middle ear under even more strain, also raising the likelihood of setbacks and even further acoustic shocks.
It further assumes that now there is also a centralized heightened neural response that is running independently upon exposure to even non noxious sound. If cochlea OHCs were repaired by FX-322, cochlea inflammation brought under control by SPI-1005, and the mid ear environment was allowed to recover, the concern with this model remains that the mid ears response to noise is now heightened. This could possibly lead to needless hypercontraction of the TTM and to further acoustic shocks at non noxious noise levels resulting once again in mid ear inflammation and TGN stimulation. However, to put a positive spin on this scenario, if the cochlea was now repaired and not subject to any further non-noxious frequency specific noise damage/stimulation, this model may indicate that only the mid ear is now at risk of further damage by a newly perceived noxious noise level across
all frequencies. It is presumably no longer at risk of damage via frequency specific stimulation of Type II afferents in the cochlea where damaged OHCs have been regenerated as presumably, support cells no longer release ATP. But, if new mid ear inflammation can possible cause ATP to diffuse through the round window, can this ATP stimulate the previously sensitized Type II afferents or cause repeat OHC damage once again? The middle ear is also presumably now no longer at risk of setbacks if they indeed do originate in a damage cochlea.
The fact that tolerance to noise does improve as recovery goes on suggests that this is not permanent however.
Of course, a brand new instance of genuinely noxious noise induced cochlea damage remains a possibility.
5.01 - Facial Pain in Setbacks Triggered by Cochlea Trigeminal Nerve Branch Stimulation due to Cochlea Inflammation
This model is quite different. Although similar key elements remain the same such as sensitized Type II afferents in the cochlea and a sensitized TGN, where it differs is how potentially the delayed facial pain is being triggered. It suggests that the cochlea inflammation is what is stimulating the TGN nerve endings in the cochlea which is then in turn causing the facial pain throughout the TGN nerve area.
Such a pathology would suggest that all symptoms (acute frequency specific pain, delayed facial pain, and importantly setbacks) are being triggered by cochlea damage and that drugs such as FX-322, SPI-1005 and possibly synapse drugs would have a very good chance of helping noxacusis in this instance.
6.01 - Post Recovery & Potential Triggers for Setbacks
This indicates that certain symptoms of an acoustic shock or setback do settle over time. Typically, although it can take weeks, months or even years, radiating facial pain as well the middle ear and the tolerance to noise can and do improve.
It assumes however that the TGN remains sensitized and also that the OHC damage and sensitized Type II afferents remain, suggesting that the threat of setbacks and repeat acoustic shocks remains in place. It also assumes that lingering TTN damage could also remain. The degree of likelihood and possibly severity of further setbacks could be relative to the level of damage that the cochlea, and mid ear currently have.
Finally the threat of setbacks being caused by heightened neural responsiveness to noise also possibly remains, however the fact that tolerance to noise does increase over time suggests this also is not permanent and decreases over time if indeed it is even a factor.